Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized open-label study of Thrombosomes versus liquid-stored platelets in bleeding thrombocytopenic adults
MOH_2020-12-03_009524Phase 2Not yet recruiting
- Sponsor
- Cellphire Therapeutics, Inc.
- Start
- Aug 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Thrombosomes in Thrombocytopenia (4 arms), sponsored by Cellphire Therapeutics, Inc. Primary endpoints: Safety of multiple doses of Thrombosomes, Efficacy on bleeding control and 1 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
Thrombosomes
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on MOH_2020-12-03_009524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-12-03_009524.